BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Share-based Compensation (2021 - 2026)

Updated

BriaCell Therapeutics (BCTX) posted Share-based Compensation of $432,207 for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 92.3% from $224,815 a year earlier and up 51.2% from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Share-based Compensation (2021 - 2026) Analysis & Trends

For the trailing twelve months through Apr 30, 2026, Share-based Compensation at BriaCell Therapeutics was $1.01 million, down 12.3% year-over-year; for FY2025 (ended Jul 31, 2025), it was $776,879, down 56.9% from FY2024.

  • Annual Share-based Compensation has declined for three consecutive fiscal years, though with a five-year compound annual growth rate of 241.0% (FY2020 to FY2025).
  • In prior fiscal years, BriaCell Therapeutics' Share-based Compensation was $1.8 million in FY2024 (-17.8%), $2.19 million in FY2023 (-28.6%), $3.07 million in FY2022 (+56.2%) and $1.97 million in FY2021.
  • The fiscal Q3 2026 figure stands as the highest quarterly Share-based Compensation since fiscal Q2 2024.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last three quarters, with an average decline of 8.9% over the last seven quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was fiscal Q1 2023, with growth of 114.6%; the weakest was fiscal Q3 2023, with a decline of 67.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 BriaCell Therapeutics 30.16 Mn 29.51 Mn - 432,207.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 432,207.00
Jan 31, 2026 285,856.00
Oct 31, 2025 294,686.00
Apr 30, 2025 224,815.00
Jan 31, 2025 285,093.00
Oct 31, 2024 266,971.00
Jul 31, 2024 377,892.00
Apr 30, 2024 392,215.00
Jan 31, 2024 500,155.00
Oct 31, 2023 533,816.00
Jul 31, 2023 533,816.00
Apr 30, 2023 281,189.00
Jan 31, 2023 266,844.00
Oct 31, 2022 1.11 Mn
Jul 31, 2022 877,947.00
Apr 30, 2022 863,627.00
Jan 31, 2022 814,876.00
Oct 31, 2021 518,134.00
Jul 31, 2021 -39,280.00
API Access

BriaCell Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCTX&period=max&api_key=YOUR_API_KEY